nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2A6—Fluorouracil—head and neck cancer	0.172	0.298	CbGbCtD
Eletriptan—CYP2D6—Hydroxyurea—head and neck cancer	0.142	0.245	CbGbCtD
Eletriptan—CYP2C9—Fluorouracil—head and neck cancer	0.0593	0.102	CbGbCtD
Eletriptan—ABCB1—Vinblastine—head and neck cancer	0.0533	0.092	CbGbCtD
Eletriptan—CYP2D6—Vinblastine—head and neck cancer	0.0502	0.0867	CbGbCtD
Eletriptan—ABCB1—Docetaxel—head and neck cancer	0.044	0.0758	CbGbCtD
Eletriptan—CYP3A4—Vinblastine—head and neck cancer	0.0319	0.0551	CbGbCtD
Eletriptan—HTR1F—trigeminal nerve—head and neck cancer	0.0302	0.243	CbGeAlD
Eletriptan—CYP3A4—Docetaxel—head and neck cancer	0.0263	0.0454	CbGbCtD
Eletriptan—HTR7—superior cervical ganglion—head and neck cancer	0.0169	0.136	CbGeAlD
Eletriptan—Arteriospasm coronary—Fluorouracil—head and neck cancer	0.0125	0.0528	CcSEcCtD
Eletriptan—HTR1B—trigeminal nerve—head and neck cancer	0.0124	0.0997	CbGeAlD
Eletriptan—HTR1D—trigeminal nerve—head and neck cancer	0.012	0.0965	CbGeAlD
Eletriptan—HTR1B—cranial nerve—head and neck cancer	0.00883	0.071	CbGeAlD
Eletriptan—HTR1D—cranial nerve—head and neck cancer	0.00855	0.0688	CbGeAlD
Eletriptan—Pain in jaw—Vinblastine—head and neck cancer	0.00846	0.0358	CcSEcCtD
Eletriptan—HTR7—cranial nerve—head and neck cancer	0.00681	0.0548	CbGeAlD
Eletriptan—Colitis ischaemic—Docetaxel—head and neck cancer	0.00444	0.0188	CcSEcCtD
Eletriptan—Lacrimal structural disorder—Docetaxel—head and neck cancer	0.00444	0.0188	CcSEcCtD
Eletriptan—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.00405	0.0171	CcSEcCtD
Eletriptan—Numbness—Vinblastine—head and neck cancer	0.00332	0.0141	CcSEcCtD
Eletriptan—Sensory loss—Vinblastine—head and neck cancer	0.00318	0.0135	CcSEcCtD
Eletriptan—Lacrimal disorder—Docetaxel—head and neck cancer	0.00292	0.0124	CcSEcCtD
Eletriptan—Bone pain—Vinblastine—head and neck cancer	0.00288	0.0122	CcSEcCtD
Eletriptan—Chest tightness—Docetaxel—head and neck cancer	0.00278	0.0118	CcSEcCtD
Eletriptan—HTR1F—head—head and neck cancer	0.00262	0.0211	CbGeAlD
Eletriptan—Photophobia—Vinblastine—head and neck cancer	0.00259	0.011	CcSEcCtD
Eletriptan—HTR7—mouth—head and neck cancer	0.00229	0.0184	CbGeAlD
Eletriptan—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00228	0.00968	CcSEcCtD
Eletriptan—HTR1E—head—head and neck cancer	0.00227	0.0183	CbGeAlD
Eletriptan—Tingling sensation—Fluorouracil—head and neck cancer	0.00225	0.00954	CcSEcCtD
Eletriptan—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00225	0.00954	CcSEcCtD
Eletriptan—Numbness—Fluorouracil—head and neck cancer	0.00218	0.00925	CcSEcCtD
Eletriptan—Speech disorder—Fluorouracil—head and neck cancer	0.0021	0.00891	CcSEcCtD
Eletriptan—Sensory loss—Fluorouracil—head and neck cancer	0.00209	0.00885	CcSEcCtD
Eletriptan—Parosmia—Docetaxel—head and neck cancer	0.00201	0.00853	CcSEcCtD
Eletriptan—HTR7—neck—head and neck cancer	0.00196	0.0158	CbGeAlD
Eletriptan—Burning sensation—Docetaxel—head and neck cancer	0.00188	0.00797	CcSEcCtD
Eletriptan—HTR1D—connective tissue—head and neck cancer	0.00176	0.0142	CbGeAlD
Eletriptan—Face oedema—Hydroxyurea—head and neck cancer	0.00176	0.00747	CcSEcCtD
Eletriptan—Photophobia—Fluorouracil—head and neck cancer	0.0017	0.0072	CcSEcCtD
Eletriptan—Angina pectoris—Vinblastine—head and neck cancer	0.00168	0.00714	CcSEcCtD
Eletriptan—Otitis media—Docetaxel—head and neck cancer	0.00168	0.00711	CcSEcCtD
Eletriptan—Oesophagitis—Fluorouracil—head and neck cancer	0.00165	0.00701	CcSEcCtD
Eletriptan—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00164	0.00697	CcSEcCtD
Eletriptan—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00162	0.00688	CcSEcCtD
Eletriptan—Euphoric mood—Fluorouracil—head and neck cancer	0.00155	0.00659	CcSEcCtD
Eletriptan—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00152	0.00644	CcSEcCtD
Eletriptan—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00152	0.00643	CcSEcCtD
Eletriptan—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00151	0.00641	CcSEcCtD
Eletriptan—Myocardial infarction—Vinblastine—head and neck cancer	0.00151	0.00641	CcSEcCtD
Eletriptan—Chest discomfort—Docetaxel—head and neck cancer	0.00148	0.00625	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00144	0.00609	CcSEcCtD
Eletriptan—Weight increased—Hydroxyurea—head and neck cancer	0.00144	0.00608	CcSEcCtD
Eletriptan—Drowsiness—Hydroxyurea—head and neck cancer	0.00141	0.00596	CcSEcCtD
Eletriptan—HTR7—connective tissue—head and neck cancer	0.0014	0.0113	CbGeAlD
Eletriptan—Amnesia—Fluorouracil—head and neck cancer	0.0014	0.00592	CcSEcCtD
Eletriptan—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00138	0.00584	CcSEcCtD
Eletriptan—Hypoaesthesia—Vinblastine—head and neck cancer	0.00138	0.00584	CcSEcCtD
Eletriptan—Pharyngitis—Vinblastine—head and neck cancer	0.00137	0.00582	CcSEcCtD
Eletriptan—Stomatitis—Hydroxyurea—head and neck cancer	0.00137	0.00581	CcSEcCtD
Eletriptan—Bone pain—Docetaxel—head and neck cancer	0.00136	0.00578	CcSEcCtD
Eletriptan—HTR7—epithelium—head and neck cancer	0.00133	0.0107	CbGeAlD
Eletriptan—Osteoarthritis—Fluorouracil—head and neck cancer	0.00131	0.00557	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00131	0.00553	CcSEcCtD
Eletriptan—Blood pressure increased—Docetaxel—head and neck cancer	0.00131	0.00553	CcSEcCtD
Eletriptan—Hallucination—Hydroxyurea—head and neck cancer	0.00126	0.00532	CcSEcCtD
Eletriptan—Candida infection—Docetaxel—head and neck cancer	0.00125	0.00528	CcSEcCtD
Eletriptan—Ataxia—Fluorouracil—head and neck cancer	0.00123	0.00523	CcSEcCtD
Eletriptan—Neuropathy—Docetaxel—head and neck cancer	0.00123	0.0052	CcSEcCtD
Eletriptan—Alopecia—Vinblastine—head and neck cancer	0.00122	0.00518	CcSEcCtD
Eletriptan—Dry skin—Fluorouracil—head and neck cancer	0.0012	0.0051	CcSEcCtD
Eletriptan—Oesophagitis—Docetaxel—head and neck cancer	0.00119	0.00506	CcSEcCtD
Eletriptan—HTR7—trachea—head and neck cancer	0.00118	0.00949	CbGeAlD
Eletriptan—Muscular weakness—Fluorouracil—head and neck cancer	0.00116	0.00491	CcSEcCtD
Eletriptan—Dysphagia—Fluorouracil—head and neck cancer	0.00113	0.00481	CcSEcCtD
Eletriptan—Chills—Hydroxyurea—head and neck cancer	0.00113	0.0048	CcSEcCtD
Eletriptan—Ill-defined disorder—Vinblastine—head and neck cancer	0.00112	0.00474	CcSEcCtD
Eletriptan—Alopecia—Hydroxyurea—head and neck cancer	0.00112	0.00473	CcSEcCtD
Eletriptan—Anaemia—Vinblastine—head and neck cancer	0.00111	0.00472	CcSEcCtD
Eletriptan—Angina pectoris—Fluorouracil—head and neck cancer	0.00111	0.00469	CcSEcCtD
Eletriptan—Thrombophlebitis—Docetaxel—head and neck cancer	0.00109	0.00464	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00109	0.00462	CcSEcCtD
Eletriptan—HTR2B—thyroid gland—head and neck cancer	0.00109	0.00877	CbGeAlD
Eletriptan—Malaise—Vinblastine—head and neck cancer	0.00109	0.0046	CcSEcCtD
Eletriptan—Vertigo—Vinblastine—head and neck cancer	0.00108	0.00459	CcSEcCtD
Eletriptan—Leukopenia—Vinblastine—head and neck cancer	0.00108	0.00457	CcSEcCtD
Eletriptan—HTR1B—head—head and neck cancer	0.00107	0.00864	CbGeAlD
Eletriptan—Convulsion—Vinblastine—head and neck cancer	0.00104	0.00442	CcSEcCtD
Eletriptan—Hypertension—Vinblastine—head and neck cancer	0.00104	0.00441	CcSEcCtD
Eletriptan—HTR1D—head—head and neck cancer	0.00104	0.00836	CbGeAlD
Eletriptan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00102	0.00432	CcSEcCtD
Eletriptan—Anaemia—Hydroxyurea—head and neck cancer	0.00102	0.0043	CcSEcCtD
Eletriptan—Discomfort—Vinblastine—head and neck cancer	0.00101	0.0043	CcSEcCtD
Eletriptan—Atrial fibrillation—Docetaxel—head and neck cancer	0.001	0.00424	CcSEcCtD
Eletriptan—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000998	0.00423	CcSEcCtD
Eletriptan—Myocardial infarction—Fluorouracil—head and neck cancer	0.000992	0.0042	CcSEcCtD
Eletriptan—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000992	0.0042	CcSEcCtD
Eletriptan—Malaise—Hydroxyurea—head and neck cancer	0.000991	0.0042	CcSEcCtD
Eletriptan—Stomatitis—Fluorouracil—head and neck cancer	0.000986	0.00418	CcSEcCtD
Eletriptan—Conjunctivitis—Fluorouracil—head and neck cancer	0.000984	0.00417	CcSEcCtD
Eletriptan—Leukopenia—Hydroxyurea—head and neck cancer	0.000983	0.00417	CcSEcCtD
Eletriptan—PTGS1—connective tissue—head and neck cancer	0.000971	0.00781	CbGeAlD
Eletriptan—HTR2B—head—head and neck cancer	0.000966	0.00778	CbGeAlD
Eletriptan—Epistaxis—Fluorouracil—head and neck cancer	0.000955	0.00405	CcSEcCtD
Eletriptan—Convulsion—Hydroxyurea—head and neck cancer	0.000952	0.00403	CcSEcCtD
Eletriptan—Sinusitis—Fluorouracil—head and neck cancer	0.000949	0.00402	CcSEcCtD
Eletriptan—Anorexia—Vinblastine—head and neck cancer	0.000937	0.00397	CcSEcCtD
Eletriptan—Migraine—Docetaxel—head and neck cancer	0.000933	0.00395	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000929	0.00394	CcSEcCtD
Eletriptan—Discomfort—Hydroxyurea—head and neck cancer	0.000924	0.00392	CcSEcCtD
Eletriptan—PTGS1—epithelium—head and neck cancer	0.000922	0.00742	CbGeAlD
Eletriptan—Rhinitis—Fluorouracil—head and neck cancer	0.000911	0.00386	CcSEcCtD
Eletriptan—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000904	0.00383	CcSEcCtD
Eletriptan—Pharyngitis—Fluorouracil—head and neck cancer	0.000902	0.00382	CcSEcCtD
Eletriptan—Oedema—Hydroxyurea—head and neck cancer	0.000897	0.0038	CcSEcCtD
Eletriptan—Ataxia—Docetaxel—head and neck cancer	0.000891	0.00378	CcSEcCtD
Eletriptan—Paraesthesia—Vinblastine—head and neck cancer	0.000883	0.00374	CcSEcCtD
Eletriptan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000879	0.00373	CcSEcCtD
Eletriptan—Liver function test abnormal—Docetaxel—head and neck cancer	0.000875	0.00371	CcSEcCtD
Eletriptan—Skin disorder—Hydroxyurea—head and neck cancer	0.000871	0.00369	CcSEcCtD
Eletriptan—Dry skin—Docetaxel—head and neck cancer	0.000869	0.00368	CcSEcCtD
Eletriptan—HTR1A—head—head and neck cancer	0.000866	0.00697	CbGeAlD
Eletriptan—Abdominal pain upper—Docetaxel—head and neck cancer	0.000866	0.00367	CcSEcCtD
Eletriptan—Anorexia—Hydroxyurea—head and neck cancer	0.000855	0.00362	CcSEcCtD
Eletriptan—Decreased appetite—Vinblastine—head and neck cancer	0.000855	0.00362	CcSEcCtD
Eletriptan—Cramp muscle—Docetaxel—head and neck cancer	0.000854	0.00362	CcSEcCtD
Eletriptan—Pain—Vinblastine—head and neck cancer	0.000841	0.00356	CcSEcCtD
Eletriptan—Constipation—Vinblastine—head and neck cancer	0.000841	0.00356	CcSEcCtD
Eletriptan—HTR7—head—head and neck cancer	0.000828	0.00666	CbGeAlD
Eletriptan—Dysphagia—Docetaxel—head and neck cancer	0.000819	0.00347	CcSEcCtD
Eletriptan—PTGS1—trachea—head and neck cancer	0.000815	0.00656	CbGeAlD
Eletriptan—Arrhythmia—Fluorouracil—head and neck cancer	0.000812	0.00344	CcSEcCtD
Eletriptan—Feeling abnormal—Vinblastine—head and neck cancer	0.00081	0.00343	CcSEcCtD
Eletriptan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000804	0.00341	CcSEcCtD
Eletriptan—Alopecia—Fluorouracil—head and neck cancer	0.000803	0.0034	CcSEcCtD
Eletriptan—Dyspnoea—Hydroxyurea—head and neck cancer	0.000799	0.00339	CcSEcCtD
Eletriptan—Angina pectoris—Docetaxel—head and neck cancer	0.000798	0.00338	CcSEcCtD
Eletriptan—Somnolence—Hydroxyurea—head and neck cancer	0.000797	0.00338	CcSEcCtD
Eletriptan—Dyspepsia—Hydroxyurea—head and neck cancer	0.000789	0.00335	CcSEcCtD
Eletriptan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000779	0.0033	CcSEcCtD
Eletriptan—Abdominal pain—Vinblastine—head and neck cancer	0.000777	0.00329	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000774	0.00328	CcSEcCtD
Eletriptan—Fatigue—Hydroxyurea—head and neck cancer	0.000773	0.00328	CcSEcCtD
Eletriptan—Pain—Hydroxyurea—head and neck cancer	0.000767	0.00325	CcSEcCtD
Eletriptan—Constipation—Hydroxyurea—head and neck cancer	0.000767	0.00325	CcSEcCtD
Eletriptan—Weight increased—Docetaxel—head and neck cancer	0.000746	0.00316	CcSEcCtD
Eletriptan—Weight decreased—Docetaxel—head and neck cancer	0.000741	0.00314	CcSEcCtD
Eletriptan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000739	0.00313	CcSEcCtD
Eletriptan—Anaemia—Fluorouracil—head and neck cancer	0.000731	0.0031	CcSEcCtD
Eletriptan—Hypersensitivity—Vinblastine—head and neck cancer	0.000724	0.00307	CcSEcCtD
Eletriptan—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00072	0.00305	CcSEcCtD
Eletriptan—Myocardial infarction—Docetaxel—head and neck cancer	0.000716	0.00303	CcSEcCtD
Eletriptan—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000716	0.00303	CcSEcCtD
Eletriptan—Stomatitis—Docetaxel—head and neck cancer	0.000712	0.00302	CcSEcCtD
Eletriptan—Conjunctivitis—Docetaxel—head and neck cancer	0.00071	0.00301	CcSEcCtD
Eletriptan—Body temperature increased—Hydroxyurea—head and neck cancer	0.000709	0.003	CcSEcCtD
Eletriptan—Leukopenia—Fluorouracil—head and neck cancer	0.000708	0.003	CcSEcCtD
Eletriptan—Asthenia—Vinblastine—head and neck cancer	0.000705	0.00299	CcSEcCtD
Eletriptan—Epistaxis—Docetaxel—head and neck cancer	0.000689	0.00292	CcSEcCtD
Eletriptan—Convulsion—Fluorouracil—head and neck cancer	0.000685	0.0029	CcSEcCtD
Eletriptan—HTR2B—lymph node—head and neck cancer	0.000677	0.00545	CbGeAlD
Eletriptan—Myalgia—Fluorouracil—head and neck cancer	0.000673	0.00285	CcSEcCtD
Eletriptan—Diarrhoea—Vinblastine—head and neck cancer	0.000673	0.00285	CcSEcCtD
Eletriptan—Discomfort—Fluorouracil—head and neck cancer	0.000665	0.00282	CcSEcCtD
Eletriptan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000661	0.0028	CcSEcCtD
Eletriptan—Rhinitis—Docetaxel—head and neck cancer	0.000657	0.00279	CcSEcCtD
Eletriptan—Hypoaesthesia—Docetaxel—head and neck cancer	0.000652	0.00277	CcSEcCtD
Eletriptan—Confusional state—Fluorouracil—head and neck cancer	0.000651	0.00276	CcSEcCtD
Eletriptan—Pharyngitis—Docetaxel—head and neck cancer	0.000651	0.00276	CcSEcCtD
Eletriptan—Dizziness—Vinblastine—head and neck cancer	0.00065	0.00276	CcSEcCtD
Eletriptan—Urinary tract disorder—Docetaxel—head and neck cancer	0.000648	0.00274	CcSEcCtD
Eletriptan—Oedema peripheral—Docetaxel—head and neck cancer	0.000646	0.00274	CcSEcCtD
Eletriptan—Oedema—Fluorouracil—head and neck cancer	0.000645	0.00274	CcSEcCtD
Eletriptan—PTGS1—thyroid gland—head and neck cancer	0.000645	0.00519	CbGeAlD
Eletriptan—Asthenia—Hydroxyurea—head and neck cancer	0.000643	0.00273	CcSEcCtD
Eletriptan—Urethral disorder—Docetaxel—head and neck cancer	0.000643	0.00272	CcSEcCtD
Eletriptan—Nervous system disorder—Fluorouracil—head and neck cancer	0.000633	0.00268	CcSEcCtD
Eletriptan—Visual impairment—Docetaxel—head and neck cancer	0.000632	0.00268	CcSEcCtD
Eletriptan—Tachycardia—Fluorouracil—head and neck cancer	0.00063	0.00267	CcSEcCtD
Eletriptan—Vomiting—Vinblastine—head and neck cancer	0.000625	0.00265	CcSEcCtD
Eletriptan—Headache—Vinblastine—head and neck cancer	0.000616	0.00261	CcSEcCtD
Eletriptan—Anorexia—Fluorouracil—head and neck cancer	0.000615	0.00261	CcSEcCtD
Eletriptan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000614	0.0026	CcSEcCtD
Eletriptan—Flushing—Docetaxel—head and neck cancer	0.000609	0.00258	CcSEcCtD
Eletriptan—Hypotension—Fluorouracil—head and neck cancer	0.000603	0.00256	CcSEcCtD
Eletriptan—Dizziness—Hydroxyurea—head and neck cancer	0.000593	0.00251	CcSEcCtD
Eletriptan—Immune system disorder—Docetaxel—head and neck cancer	0.000592	0.00251	CcSEcCtD
Eletriptan—Chills—Docetaxel—head and neck cancer	0.000588	0.00249	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000588	0.00249	CcSEcCtD
Eletriptan—Arrhythmia—Docetaxel—head and neck cancer	0.000586	0.00248	CcSEcCtD
Eletriptan—Nausea—Vinblastine—head and neck cancer	0.000584	0.00248	CcSEcCtD
Eletriptan—Insomnia—Fluorouracil—head and neck cancer	0.000584	0.00247	CcSEcCtD
Eletriptan—Paraesthesia—Fluorouracil—head and neck cancer	0.00058	0.00246	CcSEcCtD
Eletriptan—Alopecia—Docetaxel—head and neck cancer	0.000579	0.00246	CcSEcCtD
Eletriptan—Dyspnoea—Fluorouracil—head and neck cancer	0.000575	0.00244	CcSEcCtD
Eletriptan—Somnolence—Fluorouracil—head and neck cancer	0.000574	0.00243	CcSEcCtD
Eletriptan—PTGS1—head—head and neck cancer	0.000572	0.0046	CbGeAlD
Eletriptan—Vomiting—Hydroxyurea—head and neck cancer	0.00057	0.00242	CcSEcCtD
Eletriptan—Dyspepsia—Fluorouracil—head and neck cancer	0.000568	0.00241	CcSEcCtD
Eletriptan—Rash—Hydroxyurea—head and neck cancer	0.000565	0.0024	CcSEcCtD
Eletriptan—Dermatitis—Hydroxyurea—head and neck cancer	0.000565	0.00239	CcSEcCtD
Eletriptan—Headache—Hydroxyurea—head and neck cancer	0.000562	0.00238	CcSEcCtD
Eletriptan—Decreased appetite—Fluorouracil—head and neck cancer	0.000561	0.00238	CcSEcCtD
Eletriptan—Dysgeusia—Docetaxel—head and neck cancer	0.000559	0.00237	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000557	0.00236	CcSEcCtD
Eletriptan—Back pain—Docetaxel—head and neck cancer	0.000552	0.00234	CcSEcCtD
Eletriptan—Pain—Fluorouracil—head and neck cancer	0.000552	0.00234	CcSEcCtD
Eletriptan—Muscle spasms—Docetaxel—head and neck cancer	0.000549	0.00233	CcSEcCtD
Eletriptan—ABCB1—epithelium—head and neck cancer	0.000545	0.00439	CbGeAlD
Eletriptan—Nausea—Hydroxyurea—head and neck cancer	0.000533	0.00226	CcSEcCtD
Eletriptan—Feeling abnormal—Fluorouracil—head and neck cancer	0.000532	0.00225	CcSEcCtD
Eletriptan—Anaemia—Docetaxel—head and neck cancer	0.000528	0.00224	CcSEcCtD
Eletriptan—Urticaria—Fluorouracil—head and neck cancer	0.000513	0.00217	CcSEcCtD
Eletriptan—Syncope—Docetaxel—head and neck cancer	0.000512	0.00217	CcSEcCtD
Eletriptan—Leukopenia—Docetaxel—head and neck cancer	0.000511	0.00217	CcSEcCtD
Eletriptan—Body temperature increased—Fluorouracil—head and neck cancer	0.00051	0.00216	CcSEcCtD
Eletriptan—Palpitations—Docetaxel—head and neck cancer	0.000504	0.00214	CcSEcCtD
Eletriptan—Loss of consciousness—Docetaxel—head and neck cancer	0.000502	0.00213	CcSEcCtD
Eletriptan—Cough—Docetaxel—head and neck cancer	0.000498	0.00211	CcSEcCtD
Eletriptan—Convulsion—Docetaxel—head and neck cancer	0.000495	0.0021	CcSEcCtD
Eletriptan—Hypertension—Docetaxel—head and neck cancer	0.000493	0.00209	CcSEcCtD
Eletriptan—Arthralgia—Docetaxel—head and neck cancer	0.000486	0.00206	CcSEcCtD
Eletriptan—Myalgia—Docetaxel—head and neck cancer	0.000486	0.00206	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000483	0.00205	CcSEcCtD
Eletriptan—ABCB1—trachea—head and neck cancer	0.000482	0.00388	CbGeAlD
Eletriptan—Hypersensitivity—Fluorouracil—head and neck cancer	0.000476	0.00202	CcSEcCtD
Eletriptan—Dry mouth—Docetaxel—head and neck cancer	0.000475	0.00201	CcSEcCtD
Eletriptan—CYP2D6—head—head and neck cancer	0.00047	0.00378	CbGeAlD
Eletriptan—Confusional state—Docetaxel—head and neck cancer	0.00047	0.00199	CcSEcCtD
Eletriptan—Oedema—Docetaxel—head and neck cancer	0.000466	0.00197	CcSEcCtD
Eletriptan—Shock—Docetaxel—head and neck cancer	0.000458	0.00194	CcSEcCtD
Eletriptan—Nervous system disorder—Docetaxel—head and neck cancer	0.000457	0.00194	CcSEcCtD
Eletriptan—Pruritus—Fluorouracil—head and neck cancer	0.000457	0.00194	CcSEcCtD
Eletriptan—Tachycardia—Docetaxel—head and neck cancer	0.000455	0.00193	CcSEcCtD
Eletriptan—Skin disorder—Docetaxel—head and neck cancer	0.000452	0.00192	CcSEcCtD
Eletriptan—Anorexia—Docetaxel—head and neck cancer	0.000444	0.00188	CcSEcCtD
Eletriptan—Diarrhoea—Fluorouracil—head and neck cancer	0.000442	0.00187	CcSEcCtD
Eletriptan—Hypotension—Docetaxel—head and neck cancer	0.000435	0.00185	CcSEcCtD
Eletriptan—Dizziness—Fluorouracil—head and neck cancer	0.000427	0.00181	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000424	0.0018	CcSEcCtD
Eletriptan—Insomnia—Docetaxel—head and neck cancer	0.000421	0.00179	CcSEcCtD
Eletriptan—ABCB1—lymphoid tissue—head and neck cancer	0.00042	0.00338	CbGeAlD
Eletriptan—Paraesthesia—Docetaxel—head and neck cancer	0.000418	0.00177	CcSEcCtD
Eletriptan—Dyspnoea—Docetaxel—head and neck cancer	0.000415	0.00176	CcSEcCtD
Eletriptan—Somnolence—Docetaxel—head and neck cancer	0.000414	0.00176	CcSEcCtD
Eletriptan—Vomiting—Fluorouracil—head and neck cancer	0.00041	0.00174	CcSEcCtD
Eletriptan—Dyspepsia—Docetaxel—head and neck cancer	0.00041	0.00174	CcSEcCtD
Eletriptan—Rash—Fluorouracil—head and neck cancer	0.000407	0.00172	CcSEcCtD
Eletriptan—Dermatitis—Fluorouracil—head and neck cancer	0.000407	0.00172	CcSEcCtD
Eletriptan—Decreased appetite—Docetaxel—head and neck cancer	0.000405	0.00172	CcSEcCtD
Eletriptan—Headache—Fluorouracil—head and neck cancer	0.000404	0.00171	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000402	0.0017	CcSEcCtD
Eletriptan—Fatigue—Docetaxel—head and neck cancer	0.000402	0.0017	CcSEcCtD
Eletriptan—PTGS1—lymph node—head and neck cancer	0.000401	0.00322	CbGeAlD
Eletriptan—Pain—Docetaxel—head and neck cancer	0.000398	0.00169	CcSEcCtD
Eletriptan—Constipation—Docetaxel—head and neck cancer	0.000398	0.00169	CcSEcCtD
Eletriptan—Feeling abnormal—Docetaxel—head and neck cancer	0.000384	0.00163	CcSEcCtD
Eletriptan—Nausea—Fluorouracil—head and neck cancer	0.000383	0.00162	CcSEcCtD
Eletriptan—ABCB1—thyroid gland—head and neck cancer	0.000381	0.00307	CbGeAlD
Eletriptan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000381	0.00161	CcSEcCtD
Eletriptan—Body temperature increased—Docetaxel—head and neck cancer	0.000368	0.00156	CcSEcCtD
Eletriptan—Abdominal pain—Docetaxel—head and neck cancer	0.000368	0.00156	CcSEcCtD
Eletriptan—Hypersensitivity—Docetaxel—head and neck cancer	0.000343	0.00145	CcSEcCtD
Eletriptan—ABCB1—head—head and neck cancer	0.000338	0.00272	CbGeAlD
Eletriptan—Asthenia—Docetaxel—head and neck cancer	0.000334	0.00142	CcSEcCtD
Eletriptan—Pruritus—Docetaxel—head and neck cancer	0.00033	0.0014	CcSEcCtD
Eletriptan—Diarrhoea—Docetaxel—head and neck cancer	0.000319	0.00135	CcSEcCtD
Eletriptan—Dizziness—Docetaxel—head and neck cancer	0.000308	0.00131	CcSEcCtD
Eletriptan—Vomiting—Docetaxel—head and neck cancer	0.000296	0.00126	CcSEcCtD
Eletriptan—Rash—Docetaxel—head and neck cancer	0.000294	0.00124	CcSEcCtD
Eletriptan—Dermatitis—Docetaxel—head and neck cancer	0.000293	0.00124	CcSEcCtD
Eletriptan—Headache—Docetaxel—head and neck cancer	0.000292	0.00124	CcSEcCtD
Eletriptan—Nausea—Docetaxel—head and neck cancer	0.000277	0.00117	CcSEcCtD
Eletriptan—ABCB1—lymph node—head and neck cancer	0.000237	0.00191	CbGeAlD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.22e-05	0.0007	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—YAP1—head and neck cancer	4.14e-05	0.000686	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NOTCH1—head and neck cancer	3.91e-05	0.000648	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.81e-05	0.000632	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NOTCH1—head and neck cancer	3.69e-05	0.000611	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—MAPK3—head and neck cancer	3.66e-05	0.000607	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.6e-05	0.000598	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.59e-05	0.000595	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.52e-05	0.000583	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—MAPK1—head and neck cancer	3.48e-05	0.000578	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—head and neck cancer	3.48e-05	0.000577	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.48e-05	0.000577	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—MAPK3—head and neck cancer	3.45e-05	0.000573	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.43e-05	0.000569	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.43e-05	0.000569	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—PIK3CA—head and neck cancer	3.33e-05	0.000552	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NAT2—head and neck cancer	3.31e-05	0.000549	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—MAPK1—head and neck cancer	3.29e-05	0.000545	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—head and neck cancer	3.28e-05	0.000545	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NAT2—head and neck cancer	3.23e-05	0.000536	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL2—head and neck cancer	3.23e-05	0.000535	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL2—head and neck cancer	3.21e-05	0.000532	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.21e-05	0.000532	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.17e-05	0.000526	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL2—head and neck cancer	3.14e-05	0.000521	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—PIK3CA—head and neck cancer	3.14e-05	0.000521	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.13e-05	0.000519	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NAT2—head and neck cancer	3.04e-05	0.000505	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—PIK3CA—head and neck cancer	3.02e-05	0.000501	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NAT2—head and neck cancer	3.02e-05	0.000501	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.98e-05	0.000494	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	2.95e-05	0.000489	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL2—head and neck cancer	2.93e-05	0.000486	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL2—head and neck cancer	2.91e-05	0.000483	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—DPYD—head and neck cancer	2.9e-05	0.000481	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.88e-05	0.000478	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—TYMS—head and neck cancer	2.87e-05	0.000476	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PIK3CA—head and neck cancer	2.85e-05	0.000473	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL2—head and neck cancer	2.85e-05	0.000473	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTM1—head and neck cancer	2.84e-05	0.00047	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—DPYD—head and neck cancer	2.83e-05	0.00047	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—HRAS—head and neck cancer	2.8e-05	0.000464	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—YAP1—head and neck cancer	2.75e-05	0.000457	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AKT1—head and neck cancer	2.72e-05	0.000451	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GPX1—head and neck cancer	2.72e-05	0.00045	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—TYMS—head and neck cancer	2.71e-05	0.00045	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL2—head and neck cancer	2.69e-05	0.000446	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—YAP1—head and neck cancer	2.69e-05	0.000446	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP1A1—head and neck cancer	2.69e-05	0.000446	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTM1—head and neck cancer	2.68e-05	0.000445	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL2—head and neck cancer	2.68e-05	0.000444	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—DPYD—head and neck cancer	2.67e-05	0.000443	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—DPYD—head and neck cancer	2.65e-05	0.000439	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—HRAS—head and neck cancer	2.64e-05	0.000437	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCND1—head and neck cancer	2.62e-05	0.000435	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GPX1—head and neck cancer	2.57e-05	0.000426	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKT1—head and neck cancer	2.56e-05	0.000425	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP1A1—head and neck cancer	2.54e-05	0.000422	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2—head and neck cancer	2.54e-05	0.000421	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—YAP1—head and neck cancer	2.53e-05	0.00042	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTEN—head and neck cancer	2.53e-05	0.00042	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOTCH1—head and neck cancer	2.52e-05	0.000417	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—YAP1—head and neck cancer	2.51e-05	0.000417	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOTCH1—head and neck cancer	2.5e-05	0.000414	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCND1—head and neck cancer	2.47e-05	0.00041	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKT1—head and neck cancer	2.47e-05	0.000409	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOTCH1—head and neck cancer	2.45e-05	0.000406	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.43e-05	0.000403	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2—head and neck cancer	2.39e-05	0.000397	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTEN—head and neck cancer	2.39e-05	0.000396	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—MAPK3—head and neck cancer	2.36e-05	0.000391	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—MAPK3—head and neck cancer	2.34e-05	0.000388	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKT1—head and neck cancer	2.33e-05	0.000386	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	2.3e-05	0.000381	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—MAPK3—head and neck cancer	2.29e-05	0.00038	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VEGFA—head and neck cancer	2.29e-05	0.000379	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—STAT3—head and neck cancer	2.26e-05	0.000375	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—MAPK1—head and neck cancer	2.24e-05	0.000372	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—head and neck cancer	2.24e-05	0.000372	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—MAPK1—head and neck cancer	2.23e-05	0.000369	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—head and neck cancer	2.23e-05	0.000369	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.21e-05	0.000366	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—MAPK1—head and neck cancer	2.18e-05	0.000362	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—head and neck cancer	2.18e-05	0.000362	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2—head and neck cancer	2.17e-05	0.00036	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK3—head and neck cancer	2.16e-05	0.000359	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—head and neck cancer	2.16e-05	0.000358	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	2.15e-05	0.000357	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PIK3CA—head and neck cancer	2.14e-05	0.000355	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—STAT3—head and neck cancer	2.13e-05	0.000354	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PIK3CA—head and neck cancer	2.13e-05	0.000353	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.08e-05	0.000346	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.07e-05	0.000343	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK1—head and neck cancer	2.06e-05	0.000341	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—head and neck cancer	2.06e-05	0.000341	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	2.05e-05	0.00034	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	2.05e-05	0.00034	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK3—head and neck cancer	2.04e-05	0.000338	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NAT2—head and neck cancer	1.99e-05	0.00033	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	1.96e-05	0.000325	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PIK3CA—head and neck cancer	1.95e-05	0.000323	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK1—head and neck cancer	1.94e-05	0.000322	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—head and neck cancer	1.94e-05	0.000322	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PIK3CA—head and neck cancer	1.93e-05	0.000321	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PIK3CA—head and neck cancer	1.89e-05	0.000314	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.89e-05	0.000313	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOTCH1—head and neck cancer	1.86e-05	0.000309	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.8e-05	0.000299	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HRAS—head and neck cancer	1.8e-05	0.000298	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HRAS—head and neck cancer	1.79e-05	0.000297	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PIK3CA—head and neck cancer	1.79e-05	0.000296	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	1.78e-05	0.000295	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HRAS—head and neck cancer	1.75e-05	0.00029	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—head and neck cancer	1.75e-05	0.00029	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	1.75e-05	0.00029	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—DPYD—head and neck cancer	1.75e-05	0.000289	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—head and neck cancer	1.74e-05	0.000288	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—head and neck cancer	1.73e-05	0.000287	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—head and neck cancer	1.73e-05	0.000286	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—head and neck cancer	1.72e-05	0.000285	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—head and neck cancer	1.7e-05	0.000282	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCND1—head and neck cancer	1.69e-05	0.00028	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—head and neck cancer	1.68e-05	0.000279	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PIK3CA—head and neck cancer	1.68e-05	0.000279	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCND1—head and neck cancer	1.68e-05	0.000278	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	1.66e-05	0.000276	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	1.66e-05	0.000275	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—YAP1—head and neck cancer	1.66e-05	0.000275	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TYMS—head and neck cancer	1.65e-05	0.000274	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HRAS—head and neck cancer	1.65e-05	0.000274	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.65e-05	0.000273	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	1.64e-05	0.000273	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCND1—head and neck cancer	1.64e-05	0.000272	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.63e-05	0.000271	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—head and neck cancer	1.63e-05	0.00027	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTEN—head and neck cancer	1.63e-05	0.00027	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTEN—head and neck cancer	1.62e-05	0.000268	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TYMS—head and neck cancer	1.61e-05	0.000268	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	1.6e-05	0.000265	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—head and neck cancer	1.6e-05	0.000265	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—head and neck cancer	1.6e-05	0.000265	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—head and neck cancer	1.59e-05	0.000264	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.59e-05	0.000263	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTEN—head and neck cancer	1.58e-05	0.000263	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—head and neck cancer	1.58e-05	0.000262	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	1.58e-05	0.000262	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—head and neck cancer	1.57e-05	0.00026	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—head and neck cancer	1.56e-05	0.000258	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.55e-05	0.000257	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—head and neck cancer	1.55e-05	0.000256	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCND1—head and neck cancer	1.54e-05	0.000256	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—head and neck cancer	1.53e-05	0.000253	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TYMS—head and neck cancer	1.52e-05	0.000252	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.51e-05	0.000251	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.51e-05	0.000251	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TYMS—head and neck cancer	1.51e-05	0.00025	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.5e-05	0.000249	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.49e-05	0.000247	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTEN—head and neck cancer	1.49e-05	0.000247	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—head and neck cancer	1.47e-05	0.000244	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	1.46e-05	0.000242	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—head and neck cancer	1.46e-05	0.000242	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—head and neck cancer	1.46e-05	0.000242	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	1.45e-05	0.000241	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—head and neck cancer	1.45e-05	0.00024	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.44e-05	0.000239	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—head and neck cancer	1.44e-05	0.000239	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—head and neck cancer	1.43e-05	0.000237	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—head and neck cancer	1.43e-05	0.000237	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.43e-05	0.000236	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—head and neck cancer	1.42e-05	0.000235	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.41e-05	0.000234	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTEN—head and neck cancer	1.39e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK3—head and neck cancer	1.39e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	1.38e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—head and neck cancer	1.38e-05	0.000228	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK3—head and neck cancer	1.35e-05	0.000225	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	1.34e-05	0.000223	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	1.33e-05	0.000221	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—head and neck cancer	1.33e-05	0.000221	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK1—head and neck cancer	1.32e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—head and neck cancer	1.32e-05	0.00022	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTEN—head and neck cancer	1.32e-05	0.000219	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	1.32e-05	0.000218	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—head and neck cancer	1.32e-05	0.000218	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	1.3e-05	0.000215	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	1.29e-05	0.000214	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—head and neck cancer	1.29e-05	0.000214	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—head and neck cancer	1.28e-05	0.000213	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.27e-05	0.000211	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	1.27e-05	0.000211	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCND1—head and neck cancer	1.25e-05	0.000207	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	1.21e-05	0.000201	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—head and neck cancer	1.21e-05	0.000201	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	0.0002	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	0.000195	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.16e-05	0.000193	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	1.15e-05	0.000191	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	1.14e-05	0.000189	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	1.12e-05	0.000185	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—head and neck cancer	1.11e-05	0.000184	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—head and neck cancer	1.1e-05	0.000183	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	0.000181	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—head and neck cancer	1.08e-05	0.000179	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	0.000179	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—head and neck cancer	1.06e-05	0.000176	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—head and neck cancer	1.06e-05	0.000175	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.05e-05	0.000174	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—head and neck cancer	1.03e-05	0.000172	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	0.000171	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.02e-05	0.000168	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TYMS—head and neck cancer	9.95e-06	0.000165	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CA—head and neck cancer	9.84e-06	0.000163	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—head and neck cancer	9.83e-06	0.000163	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	9.81e-06	0.000163	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—head and neck cancer	9.81e-06	0.000163	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—head and neck cancer	9.71e-06	0.000161	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—head and neck cancer	9.41e-06	0.000156	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—head and neck cancer	9.39e-06	0.000156	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—head and neck cancer	9.33e-06	0.000155	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.32e-06	0.000155	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CA—head and neck cancer	9.3e-06	0.000154	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.22e-06	0.000153	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—head and neck cancer	9.13e-06	0.000151	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—head and neck cancer	9e-06	0.000149	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—head and neck cancer	8.58e-06	0.000142	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	8.52e-06	0.000141	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—head and neck cancer	8.48e-06	0.000141	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—head and neck cancer	8.4e-06	0.000139	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—head and neck cancer	8.24e-06	0.000137	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTEN—head and neck cancer	8.04e-06	0.000133	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—head and neck cancer	8.03e-06	0.000133	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—head and neck cancer	7.88e-06	0.000131	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTEN—head and neck cancer	7.85e-06	0.00013	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—head and neck cancer	7.6e-06	0.000126	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTEN—head and neck cancer	7.39e-06	0.000123	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTEN—head and neck cancer	7.33e-06	0.000122	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—head and neck cancer	6.96e-06	0.000115	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.67e-06	9.4e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.54e-06	9.19e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.53e-06	9.18e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.22e-06	8.65e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.17e-06	8.58e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTEN—head and neck cancer	4.83e-06	8.02e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—head and neck cancer	4.63e-06	7.68e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—head and neck cancer	4.52e-06	7.5e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—head and neck cancer	4.26e-06	7.07e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—head and neck cancer	4.22e-06	7.01e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.41e-06	5.66e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—head and neck cancer	2.79e-06	4.62e-05	CbGpPWpGaD
